Status:

COMPLETED

The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma

Lead Sponsor:

Istituto di Ricerca Neuroftalmologia S.r.l.

Collaborating Sponsors:

University of Milan

Conditions:

Glaucoma

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Double-blind study (OMK1 vs. Placebo) A total of 90 patients, 30 per center, will be the study sample. The study will include patients with Primary Open angle Glaucoma (glaucoma or pseudoexfoliation) ...

Eligibility Criteria

Inclusion

  • Patients with POAG and pseudoexfoliation glaucoma in one or both eyes. In the latter case, only one eye (chosen at random) will be used for the analysis.
  • Patients with -2 \< MD \< -15 dB, progression of MD at least -0,5 dB/y for 2 years.
  • Patients with tonometric compensation, i.e., IOP not above 18 mmHg. Tonometric compensation can be achieved with any type of hypotonic medical therapy and must be maintained during the 3 years of the study. If at any check-up the average of at least 3 measurements of IOP at different times is higher than 18 mmHg, the patient will be offered a new hypotonic treatment (including surgery) to control the progression of the disease. If compensation cannot be achieved (e.g., the patient refuses the proposed therapy or, in spite of this does not achieve satisfactory IOP values), the patient will be excluded from the study.
  • Patients over the age of 18 years

Exclusion

  • Patients with contraindications to citicoline
  • Patients with IOP higher than 18 mmHg
  • Patients with other forms of glaucoma
  • Patients treated with other neuroprotective therapies
  • Women who are pregnant and/or breastfeeding
  • Pediatric or adolescent patients aged under 18 years

Key Trial Info

Start Date :

September 22 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 19 2019

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04020705

Start Date

September 22 2015

End Date

March 19 2019

Last Update

July 16 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma | DecenTrialz